Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies, Illumina Added to Nasdaq-100 Index

NEW YORK (GenomeWeb News) – Life Technologies and Illumina are among the firms that have been added to the Nasdaq-100 Index.
 
Both firms will be added to the index effective Dec. 22.
 
The Nasdaq-100 was established in January 1985 and represents the largest non-financial domestic and international securities listed on the Nasdaq based on market capitalization.
 
Life Technologies, formed by the recent merger of Invitrogen and Applied Biosystems, has a market cap of around $3.8 billion. Illumina’s market cap is roughly $2.7 billion.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more